Invention Grant
- Patent Title: Methods and compositions for modulating apolipoprotein (a) expression
-
Application No.: US15401914Application Date: 2017-01-09
-
Publication No.: US09884072B2Publication Date: 2018-02-06
- Inventor: Rosanne M. Crooke , Mark J. Graham , Susan M. Freier , Marc Lim , Andrew Dibble
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Grant IP
- Main IPC: A61K31/7115
- IPC: A61K31/7115 ; A61K31/712 ; A61K31/7125
Abstract:
Disclosed herein are antisense compounds and methods for decreasing apo(a) to treat, prevent, or ameliorate diseases, disorders or conditions related to apo(a) or Lp(a). Certain diseases, disorders or conditions related to apo(a) or Lp(a) include inflammatory, cardiovascular and/or metabolic diseases, disorders or conditions. The antisense compounds disclosed herein can be used to treat such diseases, disorders or conditions in an individual in need thereof.
Public/Granted literature
- US20170182084A1 METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION Public/Granted day:2017-06-29
Information query
